- 2009 - 2012
ChairData Safety and Monitoring Committee, Advance Clinical Trial (BIIB017, pegylated interferon beta 1a) in MS, Biogen Pharmaceuticals
- 2008 - 2011
MemberExecutive Committee, National Clinical Advisory Board, National Multiple Sclerosis Society
- 2007 - 2011
MemberData Safety and Monitoring Board, Fingolimod Phase III Clinical trials for MS, Novartis Pharmaceuticals
- 2006 - present
ChairResearch Committee, Department of Neurology
- 2006 - present
Associate ChairResearch Committee, Department of Neurology
- 2006 - present
MemberDepartment of Neurology
- 2006 - present
MemberAcademic Promotions Committee, Department of Neurology
- 2006 - present
MemberMedical Advisory Board, Multiple Sclerosis Society of Canada
- 2002 - present
MemberGenomics Advisory Group, Mayo Clinic Committees
- 2001 - 2006
LiaisonDepartment of Neurology, Mayo Genomics Education Initiative, Mayo Clinic Committees
- 2001 - present
MemberClinical Working Group, Sylvia Lawry Centre for Multiple Sclerosis Research at Technical University of Munich
- 2000 - 2001
Member21125 Multicenter Clinical Trial (Direct comparison between Rebif and Avonex in relapsing remitting MS) - the EVIDENCE Trial, Serono Laboratories
- 1998 - 2002
MemberClinical and Allied Health Positions Subcommittee, Mayo Clinic Clinical Practice Committee, Mayo Clinic Committees
- 1998
Ad Hoc ReviewerScientific Research Multiple Sclerosis of Belgium
- 1998 - present
MemberAmerican Society of Human Genetics
- 1997 - 1998
Group Practice LeaderW8A Practice Group, Department of Neurology
- 1997 - 1998
MemberNeurology Practice Committee, Department of Neurology
- 1996 - 2000
MemberSteering Committee for Multicenter North American Betaseron Study in Secondary Progressive MS, Berlex Corporation
- 1996 - present
FellowAmerican Academy of Neurology
- 1996 - present
MemberAmerican Neurological Association
- 1995 - 1998
MemberCurriculum Subcommittee, Education Committee, Department of Neurology
- 1995 - present
MemberMedical Advisory Board, National Multiple Sclerosis Society
- 1994 - 1996
ReviewerScientific Program on MS and Related Topics, American Academy of Neurology
- 1994 - present
MemberResearch Committee, Department of Neurology
- 1993 - 1997
MemberMayo Foundation Chapter, Sigma Xi, The Scientific Research Society
- 1993 - 1995
MemberMayo Spinal Cord Injury Committee, Mayo Clinic Committees
- 1993
MemberNIH Ad hoc Review Committee Washington, Neuro-AIDS Consortium Program Project
- 1993 - present
Ad Hoc ReviewerNational Multiple Sclerosis Society
- 1992 - 2001
MemberMinnesota Medical Association
- 1992 - 2001
MemberAmerican Medical Association
- 1992 - 2001
MemberZumbro Valley Medical Society, Minnesota Medical Association
- 1992 - 1995
MemberGrant Review Board, Multiple Sclerosis Society of Canada
- 1991 - 1994
MemberExternal Data Safety and Monitoring Committee for Multicenter Betaseron Study in Relapsing Remitting Multiple Sclerosis, Berlex Corporation
- 1986 - 1993
MemberOntario Medical Association
- 1985 - present
MemberAmerican Academy of Neurology
- 1983 - present
FellowRoyal College of Physicians of Canada
- 1978 - 1993
MemberCanadian Medical Association
-
Ad Hoc ReviewerInternational Human Frontier Science Program
-
Ad Hoc ReviewerThe Wellcome Trust
-
MemberClinical Rating Scales for Multiple Sclerosis Task Force, National Multiple Sclerosis Society
-
MemberSteering Committee, 21125 Multicenter Clinical Trial (Direct comparison between Rebif and Avonex in relapsing remitting MS) - the EVIDENCE Trial, Serono Laboratories
-
MemberAdvisory Committee on Clinical Trials, National Multiple Sclerosis Society